Insider Trading25 Jun 2026, 04:40 pm
Bacil Pharma Closes Trading Window for Insider Trading
AI Summary
Bacil Pharma Ltd has announced the closure of its trading window for designated persons, effective July 1, 2026. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will reopen 48 hours after the conclusion of the Board of Directors' meeting, which is scheduled to consider the un-audited financial results for the quarter ended June 30, 2026. The exact date of the board meeting will be communicated separately to the stock exchanges.
Key Highlights
- Trading window closed for designated persons from July 1, 2026.
- Closure is for considering Q1 FY27 un-audited financial results.
- Window reopens 48 hours post-Board Meeting.
- Insider trading regulations are being followed.
- Board meeting date to be announced separately.
Price Impact
More from BACPHAR